NEXPLANON

Peak

etonogestrel

NDAIMPLANTATIONIMPLANT
Approved
Jul 2006
Lifecycle
Peak
Competitive Pressure
8/100
Clinical Trials
13

Mechanism of Action

ovulation, increased viscosity of the cervical mucus, and alterations in the endometrium.

Pharmacologic Class:

Progestin

Clinical Trials (5)

NCT04882137N/AWithdrawn

Barriers to Referring Adolescent Women for Etonogestrel Implant.

Started Sep 2023
0
Contraceptive Usage
NCT05994599Phase 1Completed

Comparative Bioavailability Study of Ethinyl Estradiol/Etonogestrel Vaginal Ring

Started Jul 2023
36 enrolled
Healthy WomenFemaleContraception
NCT04676061Phase 4Terminated

Effects of a Progestin on Frequent and/or Prolonged Bleeding With Nexplanon™

Started Feb 2021
51 enrolled
Birth ControlContraceptionImplant+2 more
NCT04558229Phase 4Active Not Recruiting

RCT Evaluating Standardized Counseling on Early Discontinuation for Irregular Bleeding in Nexplanon Users

Started Nov 2020
348 enrolled
Birth ControlContraceptionContraceptive Usage+1 more
NCT04423055Phase 4Completed

Nexplanon Use in Women Primarily Choosing a Combined Oral Contraceptive

Started Aug 2020
120 enrolled
Contraception

Loss of Exclusivity

LOE Date
Jul 28, 2030
53 months away
Patent Expiry
Jul 28, 2030
Exclusivity Expiry
Jan 16, 2029

Patent Records (4)

Patent #ExpiryTypeUse Code
8888745
Aug 28, 2026
Product
10821277
May 31, 2027
Product
8722037
Sep 28, 2027
Product
9757552
Jul 28, 2030
Product
U-1